VDAC1 and colitis: Recent studies from our group using animal models of inflammatory diseases such as arthritis and colitis have demonstrated that depleting or inhibiting VDAC1 reduced inflammation and alleviated other symptoms [61], suggesting its role in modulating inflammatory processes.